Abiopharma

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Lipella Pharmaceuticals Inc. - Common Stock.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Lipella Pharmaceuticals Inc. - Common Stock.

Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid

Dupixent® (dupilumab) Approved in the U.S. as the Only Targeted Medicine to Treat Patients with Bullous Pemphigoid (BP)

Q & M Dental Group (Singapore) Limited - Announcement

Netflix’s Movie Momentum in 2025: Big Names and Blockbusters

Employee Stock Option/ Share Scheme: ISSUANCE OF SHARES PURSUANT TO ENTERPRISE OPTION SCHEME

NASDAQ traded attribute type Financial_Status was changed. Previous value: N. New value: Lipella Pharmaceuticals Inc. - Common Stock.

NASDAQ traded attribute type Security_Name was changed. Previous value: Lipella Pharmaceuticals Inc. - Common Stock. New value: Lipella Pharmaceuticals Inc. - Common Stock.

NASDAQ traded attribute type Test_mode was changed. Previous value: N. New value: Lipella Pharmaceuticals Inc. - Common Stock.

Cygnus lève 18,3 M$ pour accélérer la croissance de ses ressources et ses études minières

Cygnus raises $18.3m to accelerate resource growth and mining studies

Madison Pacific Properties Inc. (TSX: MPC and MPC.C) announces results of Annual General Meeting

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Belo Sun Announces Planned Executive Leadership Transition